Hematopoietic stem cell therapy for type 1 diabetes: Induction of tolerance and islet cell neogenesis

Autoimmunity Reviews

Volumn 1, Issue 3, 2002, Pages 133-138

  Burt, Richard K ^a   Oyama, Yu ^a   Traynor, Ann ^a   Kenyon, Norma S ^b  

^a NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Islet cell neogenesis; Stem cell therapy; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; CYCLOPHOSPHAMIDE; INSULIN; THYMOCYTE ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; CELL LINEAGE; CELL REGENERATION; EMBRYO CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOGLYCEMIA; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; NONHUMAN; PANCREAS ISLET CELL; RISK BENEFIT ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 1542509670     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00033-2     Document Type: Review

References (33)

1. Bach J.F., Mathis D. The NOD mouse. Res. Immunol. 148:(5):1997;285-286.
2. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322:(26):1990;1836-1841.
3. Harrison L.C., Honeyman M.C., Deaizpurua H.J., et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:(8857):1993;1365- 1369.
4. Bonifacio E., Bingley P.J., Shattock M., et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 335:(8682):1990;147-149.
5. Lampeter E.F., Homberg M., Quabeck K., et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 341:(8855):1993;1243-1244.
6. Stiller C.R., Dupre J., Gent M., et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 223:(4643):1984;1362-1367.
7. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Investig. 99:(3):1997;457-468.
8. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173:(3):1990;932-939.
9. Nathan D.M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 328:(23):1993;1676-1685.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl. J. Med. 329:1993;977-986.
11. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes. 45:1996;1289-1298.
12. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 44:1995;968-983.
13. Lawson M.L., Gerstein H.C., Tsui E., Zinman B. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diab. Care. 22:(Suppl 2):1999;B35-B39.
14. The Diabetes Control and Complications Trial Research Group, Anonymous. Hypoglycemia in the diabetes control and complications trial. Diabetes. 46:(2):1997;271-286.
15. The Diabetes Control and Complications Trial Research Group, Anonymous. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. J. Am. Med. Assoc. 276:(17):1996;1409-1415.
16. Home P.D. Intensive insulin therapy in clinical practice. Diabetologia. 40:(Suppl 2):1997;S83-S87.
17. Azar S.T., Kanaan N. Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children with type 1 diabetes. Diab. Care. 22:(8):1999;1372-1373.
18. Ikehara S., Ohtsuki H., Good R.A., et al. Prevention of type 1 diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc. Natl Acad. Sci. USA. 8222:1985;7743-7747.
19. LaFace D.M., Peck A.B. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes. 38:(7):1989;894-901.
20. Karussis D., Vourka-Karussis U., Mizrachi-Koll R., Abramsky O. Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation. Multiple Scler. 5:(1):1999;17-21.
21. van Gelder M., van Bekkum D.W. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant. 18:(6):1996;1029-1034.
22. Burt R.K., Burns W., Ruvolo P., et al. Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 41:(4):1995;526-531.
23. Knaan-Shanzer S., Houben P., Kinwel-Bohre E.P., van Bekkum D.W. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 8:(5):1991;333-338.
24. Burt R.K., Slavin S., Burns W.H., Marmont A.M. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood. 99:(3):2002;768-784.
25. Metcalfe K.A., Hitman G.A., Rowe R.E., et al. Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diab. Care. 24:(5):2001;838-842.
26. Abiru N., Yu L., Redondo M., Eisenbarth G.S. Modification of the environment is not the most efficient way to prevent type 1 diabetes. Diab. Technol. Therapeut. 2:(4):2000;609-616.
27. Sanders J.E., Hawley J., Levy W., et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 87:(7):1996;3045-3052.
28. Rafaeloff R., Pittenger G.L., Barlow S.W., et al. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. Clin. Investig. 99:(9):1997;2100-2109.
29. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:(3):2001;369-377.
30. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med. 6:(11):2000;1229-1234.
31. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science. 284:(5417):1999;1168-1170.
32. Mezey E., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 290:(5497):2000;1779-1782.
33. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature. 406:(6793):2000;2057.